Seed VC · Hong Kong
ORI Capital invests in innovative early-stage biotech companies globally, in the areas of diagnostics, drug delivery, and therapeutics focused on the disease areas with the highest mortality rates: cancer, cardiovascular and neurodegenerative diseases.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Healthcare providers
Geography
Global
+ 2 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Ori Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Ori Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Ori Capital is one of them, and we'll tell you exactly where they sit in your top 100.